Inactivation of medium-chain acyl-CoA dehydrogenase by oct-4-en-2-ynoyl-CoA

被引:9
|
作者
Zeng, J [1 ]
Deng, GS [1 ]
Yu, WH [1 ]
Li, D [1 ]
机构
[1] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China
关键词
acyl-CoA dehydrogenase; oct-4-en-2-ynoyl-CoA; Michael addition; diabetes;
D O I
10.1016/j.bmcl.2005.10.106
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Mitochondrial medium-chain acyl-CoA dehydrogenase is a key enzyme for the beta-oxidation of fatty acids, which catalyzes the FAD-dependent oxidation of a variety of acyl-CoA Substrates to the corresponding trans-2-enoyl-CoA thioesters. Oct-4-en-2-ynoyl-CoA was identified as a new irreversible inhibitor of acyl-CoA dehydrogenase, and kinetic parameters K-I and k(inact) were determined to be 11 mu M and 0.025 min(-1), respectively. Triple bond between C2 and C3 of the inhibitor was identified as the functional group responsible for enzyme inactivation, and Michael addition is proposed as the mechanism for this inactivation, which is a new pathway for inactivation of MCAD by inhibitors. The inhibitor may become a lead for further development for treating non-insulin dependent diabetes mellitus. (C) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1445 / 1448
页数:4
相关论文
共 50 条
  • [1] Oct-2-en-4-ynoyl-CoA as a specific inhibitor of acyl-CoA oxidase
    Zeng, Jia
    Wu, Long
    Zhang, Xiaojian
    Liu, Yuandong
    Deng, Guisheng
    Li, Ding
    ORGANIC LETTERS, 2008, 10 (19) : 4287 - 4290
  • [2] Medium-chain acyl-CoA dehydrogenase deficiency in Spain
    Martinez, G
    Ribes, A
    Briones, P
    Rodés, M
    Baldellou, A
    Pineda, M
    Rodrigo, C
    Lorente, I
    García-Silva, MT
    Riudor, E
    Jaraba, P
    Lopez-Casas, J
    Nuñez-Roldan, A
    JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (06) : 693 - 694
  • [3] MEDIUM-CHAIN ACYL-COA DEHYDROGENASE-DEFICIENCY
    EGIDIO, RJ
    FRANCIS, GL
    COATES, PM
    HALE, DE
    ROESEL, A
    AMERICAN FAMILY PHYSICIAN, 1989, 39 (05) : 221 - 226
  • [4] Mutations of human medium-chain acyl-CoA dehydrogenase
    Udvari, S
    Bross, P
    Andresen, BS
    Gregersen, N
    Engel, PC
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1998, 26 (01) : S65 - S65
  • [5] Hyperuricaemia and medium-chain acyl-CoA dehydrogenase deficiency
    Mayatepek, E
    Koch, HG
    Hoffmann, GF
    JOURNAL OF INHERITED METABOLIC DISEASE, 1997, 20 (06) : 842 - 843
  • [6] Oxidative inactivation of a charge transfer complex in the medium-chain acyl-CoA dehydrogenase
    Schaller, RA
    Thorpe, C
    BIOCHEMISTRY, 1995, 34 (50) : 16424 - 16432
  • [7] IMMUNOCHEMICAL CHARACTERIZATION OF VARIANT MEDIUM-CHAIN ACYL-COA DEHYDROGENASE IN FIBROBLASTS FROM PATIENTS WITH MEDIUM-CHAIN ACYL-COA DEHYDROGENASE-DEFICIENCY
    COATES, PM
    INDO, Y
    YOUNG, D
    HALE, DE
    TANAKA, K
    PEDIATRIC RESEARCH, 1992, 31 (01) : 34 - 38
  • [8] Probing the catalytic reaction of medium-chain acyl-CoA dehydrogenase with 2-fluorooctanoyl-CoA
    Stankovich, Marian T.
    Luo, Lian
    Holt, Erica
    Zheng, Hui
    Lipscomb, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232 : 698 - 698
  • [9] Thermodynamic regulation of medium-chain acyl-CoA dehydrogenase.
    Lamm, TR
    Kohls, T
    Stankovich, MT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U111 - U112
  • [10] Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency
    Pourfarzam, M
    Morris, A
    Appleton, M
    Craft, A
    Bartlett, K
    LANCET, 2001, 358 (9287): : 1063 - 1064